David George Lowe - Net Worth and Insider Trading
David George Lowe Net Worth
The estimated net worth of David George Lowe is at least $128 dollars as of 2024-11-13. David George Lowe is the Director, 10% Owner of ARCA biopharma Inc and owns about 5 shares of ARCA biopharma Inc (ABIO) stock worth over $128. Details can be seen in David George Lowe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David George Lowe has not made any transactions after 2009-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David George Lowe
David George Lowe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David George Lowe owns 2 companies in total, including Spyre Therapeutics Inc (SYRE) , and ARCA biopharma Inc (ABIO) .
Click here to see the complete history of David George Lowe’s form 4 insider trades.
Insider Ownership Summary of David George Lowe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2016-04-06 | director & CEO and President |
| ABIO | ARCA biopharma Inc | 2009-07-17 | director |
David George Lowe Latest Holdings Summary
David George Lowe currently owns a total of 1 stock. David George Lowe owns 5 shares of ARCA biopharma Inc (ABIO) as of January 27, 2009, with a value of $128.
Latest Holdings of David George Lowe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABIO | ARCA biopharma Inc | 2009-01-27 | 5 | 25.50 | 128 |
Holding Weightings of David George Lowe
David George Lowe Form 4 Trading Tracker
According to the SEC Form 4 filings, David George Lowe has made a total of 0 transactions in ARCA biopharma Inc (ABIO) over the past 5 years. The most-recent trade in ARCA biopharma Inc is the sale of 0 shares on January 27, 2009, which brought David George Lowe around $0.
Insider Trading History of David George Lowe
- 1
David George Lowe Trading Performance
David George Lowe Ownership Network
Ownership Network List of David George Lowe
Ownership Network Relation of David George Lowe
David George Lowe Owned Company Details
What does Spyre Therapeutics Inc do?
Who are the key executives at Spyre Therapeutics Inc?
David George Lowe is the director & CEO and President of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .
Spyre Therapeutics Inc (SYRE) Insider Trades Summary
Over the past 18 months, David George Lowe made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 7,000 shares made by Jeffrey W. Albers , and a net sale of 18,531 shares made by Scott L Burrows .
In summary, during the past 3 months, insiders sold 25,531 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 25,531 shares. During the past 18 months, 25,531 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,531 shares.
Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spyre Therapeutics Inc Insider Transactions
David George Lowe Mailing Address
Above is the net worth, insider trading, and ownership report for David George Lowe. You might contact David George Lowe via mailing address: 525 University Ave., Suite 520, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
